Curiox Biosystems

Curiox Biosystems is revolutionizing the field of suspension cell sample preparation with innovative technologies that address some of the biggest challenges in research and clinical diagnostics. Our groundbreaking Laminar Wash™ technology and C-Free™ platform set new standards for efficiency, precision, and ease, making us the most exciting company in the suspension cell sample prep space today. The Laminar Wash™ system is designed to improve the quality of cell preparation by eliminating the traditional centrifugation steps that can disrupt cell integrity. This approach not only saves time but also enhances sample viability and consistency, leading to more accurate and reproducible results. Our C-Free™ platform takes automation to a new level, delivering customized, hands-free solutions that enable labs to streamline processes and maintain complete control over sample handling. By removing manual steps, C-Free™ offers unprecedented precision in cell prep, helping researchers achieve cleaner data with greater efficiency. In 2023, Curiox Biosystems marked a major milestone by going public on the KOSDAQ exchange in Korea, a testament to our growth, innovation, and industry impact. This achievement has fueled our momentum as we expand both in personnel and technology, adding talent and resources to support our vision of transforming life sciences. With a growing portfolio of solutions and a talented team dedicated to pushing the boundaries of what’s possible, Curiox Biosystems is a company to watch.